FDA Approvals Influencing Biopsy Market Expansion
The Cancer Biopsy Market, valued at USD 32.26 billion in 2024 with a CAGR of 8.23%, is growing due to rising global cancer cases and increasing demand for accurate, early diagnosis. Advancements in minimally invasive biopsies, liquid biopsy, and molecular testing are improving detection an
